Cellular and molecular regulators play a pivotal role in non-neoplastic immune-mediated diseases, where the immune system ...

Immune checkpoint inhibitors are cancer therapeutics that have shown remarkable success in extending lives in many cancers, including melanoma, MSI-high cancers, and other cancers. However, these ...

SAN DIEGO--(BUSINESS WIRE)--Candid Therapeutics, Inc. (“Candid”), a clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell engagers ...

In a new study that combines synthetic biology with cancer immunotherapy, researchers from the Yong Loo Lin School of ...

Aera Therapeutics, a biotechnology company harnessing next-generation enabling delivery technologies and precision payloads to unlock the full potential of genetic medicines, today presented ...

Seeing the global biopharmaceutical company Creative Biolabs grow its portfolio of antibody engineering has marked a ...

In a major step toward faster and more personalized cancer treatment, scientists have unveiled a powerful AI-driven method that creates custom-designed immune therapies in just weeks. Instead of ...

Cutaneous squamous-cell carcinoma (SCC) is primarily caused by oncogenesis mediated by ultraviolet radiation, and β-human papillomavirus (β-HPV) is believed to be a mere facilitator that is ...

Details and references regarding individual diseases are provided in the Supplementary Appendix. CIDP denotes chronic inflammatory demyelinating polyneuropathy, Covid-19 coronavirus disease 2019, and ...

Most patients with rheumatoid arthritis (RA) treated with upadacitinib and methotrexate had robust antibody and T-cell responses to the recombinant zoster vaccine (Shingrix; GSK), according to 60-week ...